Pregnancy after treatment of breast cancer in young women does not adversely affect the prognosis

Breast

Volumn 21, Issue 3, 2012, Pages 272-275

  Córdoba, Octavi ^a   Bellet, Meritxell ^a   Vidal, Xavier ^b   Cortés, Javier ^a   Llurba, Elisa ^a   Rubio, Isabel T ^a   Xercavins, Jordi ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Breast neoplasms; Pregnancy; Retrospective studies; Treatment outcome

Indexed keywords

ANTHRACYCLINE; BRCA2 PROTEIN; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; HORMONE; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; DEPRESSION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTECTION; RECURRENCE FREE SURVIVAL; UNWANTED PREGNANCY;

EID: 84862508979     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.10.001     Document Type: Article

References (31)

1. Ventura S.J., Abma J.C., Mosher W.D., Henshaw S.K. Estimated pregnancy rates by outcome for the United States, 1990-2004. Natl Vital Stat Rep 2008, 56:1-26.
2. Pollán M., Pastor-Barriuso R., Ardanaz E., Arguelles M., Martos C., Galceran J., et al. Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Instr 2009, 101:1584-1591.
3. Jeruss J.S., Woodruff T.K. Preservation of fertility in patients with cancer. N Engl J Med 2009, 360:902-911.
4. Krychman M.L., King T. Pregnancy after breast cancer: a case study resolving the reproductive challenge with a gestational surrogate. Breast J 2006, 12:363-365.
5. Gerber B., Dieterich M., Müller H., Reimer T. Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Treat Res 2008, 108:1-17.
6. Lambe M., Hsieh C.C., Chan H.W., Ekbom A., Trichopoulos D., Adami H.O. Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Treat Res 1996, 38:305-311.
7. Wohlfahrt J., Andersen P.K., Mouridsen H.T., Melbye M. Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 2001, 153:1079-1084.
8. Whiteman M.K., Hillis S.D., Curtis K.M., McDonald J.A., Wingo P.A., Marchbanks P.A. Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 2004, 104:146-154.
9. Aebi S., Gelber S., Castiglione-Gertsch M., Gelber R.D., Collins J., Thurlimann B., et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?. Lancet 2000, 355:1869-1874.
10. Walshe J.M., Denduluri N., Swain S.M. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006, 24:5769-5779.
11. Goel S., Sharma R., Hamilton A., Beith J. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women. Cochrane Database Syst Rev 2009, Issue 4 Art. No.: CD004562. 10.1002/14651858.CD004562.pub4.
12. Partridge A.H., Gelber S., Peppercorn J., Ginsburg E., Sampson E., Rosenberg R., et al. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 2008, 8:65-69.
13. Blakely L.J., Buzdar A.U., Lozada J.A., Shullaih S.A., Hoy E., Smith T.L., et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 2004, 100:465-469.
14. Schover L.R., Rybicki L.A., Martin B.A., Bringelsen K.A. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999, 86:697-709.
15. Kroman N., Jensen M.B., Wohlfahrt J., Ejlertsen B. Pregnancy after treatment of breast cancer-a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol 1999, 47:545-549.
16. Bines J., Oleske D.M., Cobleigh M.A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996, 14:1718-1729.
17. Buijs C., Willemse P.H., de Vries E.G., Ten Hoor K.A., Boezen H.M., Hollema H., et al. Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients. Int J Gynecol Cancer 2009, 19:677-681.
18. Mourits M.J., de Vries E.G., ten Hoor K.A., van der Zee A.G., Willemse P.H. Beware of amenorrhea during tamoxifen: it may be a wolf in sheep's clothing. J Clin Oncol 2007, 25:3787-3789.
19. Smith I.E., Dowsett M., Yap Y.S., Walsh G., Lonning P.E., Santen R.J., et al. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines. J Clin Oncol 2006, 24:2444-2447.
20. Dalberg K., Eriksson J., Holmberg L. Birth outcome in women with previously treated breast cancer-a population-based cohort study from Sweden. Plos Med 2006, 3:e336.
21. von Schoultz E., Johansson H., Wilking N., Rutqvist L.E. Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 1995, 13:430-434.
22. Velentgas P., Daling J.R., Malone K.E., Weiss N.S., Williams M.A., Self S.G., et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 1999, 85:2424-2432.
23. Ives A., Saunders C., Bulsara M., Semmens J. Pregnancy after breast cancer: population based study. BMJ 2007, 334:194.
24. Gelber S., Coates A.S., Goldhirsch A., Castiglione-Gertsch M., Marini G., Lindtner J., et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 2001, 19:1671-1675.
25. Mueller B.A., Simon M.S., Deapen D., Kamineni A., Malone K.E., Daling J.R. Childbearing and survival after breast carcinoma in young women. Cancer 2003, 98:1131-1140.
26. Russo J., Moral R., Balogh G.A., Mailo D., Russo I.H. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005, 7:131-142.
27. Kroman N., Jensen M.B., Melbye M., Wohlfahrt J., Mouridsen H.T. Should women be advised against pregnancy after breast-cancer treatment?. Lancet 1997, 350:319-322.
28. Dent R., Trudeau M., Pritchard K.I., Hanna W.M., Kahn H.K., Sawka C.A., et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007, 13:4429-4434.
29. Pagani O., Price K.N., Gelber R.D., Castiglione-Gertsch M., Holmberg S.B., Lindtner J., et al. Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast Cancer Res Treat 2009, 117:319-324.
30. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
31. Saphner T., Tormey D.C., Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 1996, 14:2738-2746.